Simona King

Medical Marijuana Giant Aurora Will Soon Report Earnings, Here's What Investors Need To Know

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 am Eastern Time. The Canadian medical cannabis giant said it will report its financial results for the first quarter of 2025 before the opening of markets that same day. CEO Miguel Martin and CFO Simona King will host the conference call and question and answer period. Aurora made headlines last week as it was granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). The permits granted the company continued domestic cultivation, which has been underway for two years.

Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes

Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as The Hempshire Group's new CEO. Los Angeles-based STIIIZY INC. named Isaac Kim its new CFO earlier this month. Another California-based cannabis operator Lowell Farms appointed Jamie Schniedwind as its new director of finance. The Colorado-based medical cannabis pioneer Charlotte's Web Holdings tapped Matthew E. McCarthy, the former CEO of Ben & Jerry's Homemade, to serve on its board earlier this month. Aurora Cannabis has named Simona King, a former executive of Bristol Myers-Squibb, its new CFO.